Navigation Links
Takeda Responds to Announcement about Suspension of Rosiglitazone Marketing Authorization in Europe and Restrictions in the U.S.
Date:9/23/2010

DEERFIELD, Ill. and LONDON, Sept. 23 /PRNewswire/ -- Following today’s announcements by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for rosiglitazone in the U.S. and Europe, Takeda Pharmaceuticals North America, Inc. and Takeda Pharmaceuticals Europe Limited (“Takeda”) underscore the company’s commitment to ACTOS® (pioglitazone HCl) and ACTOS-containing medications, and to the millions of people living with type 2 diabetes.

As this news may cause concern or confusion among people with type 2 diabetes, Takeda encourages those with questions to speak with their health care provider. Takeda has consistently emphasized the importance of physician education and patient safety in communications involving ACTOS, and has prioritized communicating the appropriate use of ACTOS in patients with type 2 diabetes.

ACTOS is an effective prescription medication used with diet and exercise to improve blood sugar (glucose) control in many adults with type 2 diabetes. Since its launch, more than 100 million ACTOS prescriptions have been written globally. ACTOS offers an established safety profile regarding the risk of cardiovascular (CV) events in people living with type 2 diabetes. Although drugs may be in the same class and have the same use, they also may have different effects due to their unique chemical structure.

Takeda remains confident in the breadth, depth and consistency of ACTOS data. Controlled clinical studies, conducted over the past 11 years in more than 20,000 patients globally, show no evidence that ACTOS is associated with an increased risk of heart attack, stroke or death.

In 2005, Takeda was the first company to complete a rigorous, randomized, placebo-controlled study, the PROactive (PROspective PioglitAzone Clinical Trial In MacroVascular Events) trial, assessing significant CV outcomes in people livi
'/>"/>

SOURCE Takeda Pharmaceutical North America, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Arthritis Foundation and Takeda Launch First-Ever National Gout Public Service Announcement (PSA) Campaign, Urging People Living With Gout to Keep Enjoying Lifes Simple Pleasures
2. Orexigen® Therapeutics and Takeda Enter Into Partnership to Commercialize Contrave® in North America
3. Takeda Responds to FDA Advisory Committee Recommendation
4. Takeda Provides Update on Patent Litigation for ACTOS(R) (pioglitazone HCl) and ACTOplus met(R) (pioglitazone HCl and metformin HCl) in the U.S.
5. CellCentric Licenses Novel Epigenetic Discovery Programme to Takeda
6. Amylin and Takeda Announce Decision to Advance Development of Pramlintide/Metreleptin Combination Treatment for Obesity
7. Takeda Announces Initiation of Trial to Study the Concomitant Use of Dexlansoprazole and Other Proton Pump Inhibitors with Plavix(R) (clopidogrel bisulfate)
8. Emerging Agents from Theravance/Astellas, Johnson & Johnson/Basilea and Forest/Astrazeneca/Takeda Will Drive Modest Growth in the MRSA Drug Market Through 2018
9. Takeda San Francisco, Inc. Appoints Michael Buckley, Ph.D. Vice President of Process Sciences
10. Takeda to Establish Four Sales and Marketing Subsidiaries to Expand Its Operations in Mexico, Turkey and Five Other Countries in Europe
11. Takeda Receives FDA Complete Response Letter for the Investigational Fixed-Dose Combination of alogliptin and ACTOS(R) (pioglitazone HCl) for the Treatment of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Utah , Aug. 29, 2014  BC Technical, ... has acquired Polaris Medical Imaging, a leader in sales, ... This strategic acquisition allows BC Technical to continue to ... specifically within MR and CT modalities. ... service," said Mark Alvarez , president and CEO ...
(Date:8/29/2014)... Does your doctor know what you,re smoking?  Chances ... marijuana to the over 112,000 currently registered patients under ... the other roughly 20,300+ active physicians listed with the Colorado ... – even though a poll in February 2014 showed 51% ... tried it. "With marijuana legalization underway, every ...
(Date:8/29/2014)... 29, 2014 Diseases largely eradicated in ... are returning. Measles was declared eliminated in 2000, yet ... of August 15—the highest incidence in 20 years. In ... declared whooping cough a problem of "epidemic proportions." ... and dying from these preventable diseases—in part because some ...
Breaking Medicine Technology:BC Technical Acquires Polaris Medical Imaging 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 3Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 4Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3
... (OMX Nordic: ACTI) presented,pre-clinical results for the ... League Against Rheumatism, <a target="_blank" href=,"http://www.eular.org/">www.eular.org ... data presented show that I-3D has a,significant ... model for rheumatoid arthritis (RA)", commented Sven,Andréasson, ...
... Percent Fewer RA Patients,Reported Job Loss When ... Alone, BARCELONA, Spain, June 15, 2007 /PRNewswire-FirstCall/ ... most common causes of,disability in the Western ... arthritis (RA) patients treated with Abbott's HUMIRA(R),(adalimumab) ...
Cached Medicine Technology:New Positive Pre-clinical Data for Active Biotech's RA Project I-3D 2Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 2Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 3Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 4Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 5Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 6Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 7
(Date:8/30/2014)... August 30, 2014 Patients suffering from ... disorder in a new review published by Daily Gossip. ... deal with, so there is no wonder that numerous ... The Natural Vitiligo Treatment is one of the most ... Vitiligo Treatment promises to stop the spread of this ...
(Date:8/30/2014)... Daily Gossip reveals in its recently published review that the ... Sarah Summer, who can perfectly understand what suffering from yeast ... actually had to deal with this disorder, too. Her method ... it, in an all-natural holistic cure program. , So, Sarah ... for yeast infection. The author of this program suffered from ...
(Date:8/30/2014)... Delhi, India (PRWEB) August 30, 2014 ... introduced low cost SEO service for small businesses. , ... or start-ups cannot afford costly search engine optimization service. ... budget of small businesses into account. , On ... said, “We have introduced this low cost SEO service ...
(Date:8/30/2014)... (PRWEB) August 30, 2014 After ... the country for the past several years, Dr. ... Hyperbaric Center have announced a scholarship program for ... announcement follows a meeting held this summer to ... recent years, reporters have shed light on the ...
(Date:8/30/2014)... (PRWEB) August 30, 2014 Seniors Guide, the ... recently that focus on Alzheimer’s Disease, Dementia, and Memory ... to the public of being diagnosed with the Alzheimer’s, inspired ... movie, “I’ll Be Me”. The movie, out on October ... focusing on his diagnosis of the disease – which inspires ...
Breaking Medicine News(10 mins):Health News:Natural Vitiligo Treatment Review Exposes Fast Method for Skin Repigmentation 2Health News:Natural Cure for Yeast Infection Review Exposes New Natural Treatment 2Health News:RBSEO Services Introduces Low Cost SEO Service for Small Businesses 2Health News:Tennessee Hyperbaric Center Offering HBOT Scholarships to Veterans 2Health News:Alzheimer’s Disease and Dementia Focus on Retirement Website SeniorsGuideOnline.com 2
... Stop-smoking services available for all Minnesotans, MINNEAPOLIS, ... can give their mothers and themselves the gift ... opportunity to quit smoking for Mom,or for mothers ... can,help Minnesotans quit smoking, whether it,s on Mother,s ...
... Inc. (OTC,Bulletin Board: AIMM) today reported a net loss ... the three months ended March 31, 2008,compared with net ... and,diluted, for the three months ended March 31, 2007. ... in cash and marketable securities as,compared to $8.8 million ...
... Next week, May 11-17, is National Hospital,Week. Texas ... Texas,hospitals., AUSTIN, Texas, May 9 As ... Week May 11-17, the Texas,Hospital Association is emphasizing ... new section on advance directives.,Consumers can visit ...
... CIGNA HealthCare of Arizona and Catholic,Healthcare West ... plan,members will have in-network access to the ... facilities and providers. The contract covers,Catholic Healthcare ... and Medical Center, Chandler Regional Medical Center, ...
... who take up the habit , , FRIDAY, May 9 (HealthDay ... their everyday conversations with peers helps reduce smoking rates, according ... included almost 11,000 students, ages 12 to 13, at 59 ... schools, certain students were selected to receive training about the ...
... HOPKINTON, Mass., May 9 Alseres,Pharmaceuticals, Inc. (Nasdaq: ... host a,conference call on Thursday, May 15th, 2008 ... March 31, 2008 and discuss other matters related ... To access the conference call, please dial ...
Cached Medicine News:Health News:QUITPLAN(R) Services Can Help Make Mother's Day Smoke-Free 2Health News:AutoImmune Inc. Reports 2008 First Quarter Financial Results 2Health News:AutoImmune Inc. Reports 2008 First Quarter Financial Results 3Health News:Web Site Helps Patients Prepare for Hospital Stay 2Health News:Web Site Helps Patients Prepare for Hospital Stay 3Health News:CIGNA HealthCare of Arizona and Catholic Healthcare West Reach Agreement 2Health News:Training Student Leaders Cuts Peers' Smoking Rates 2Health News:Alseres Pharmaceuticals to Host 2008 First Quarter Conference Call 2Health News:Alseres Pharmaceuticals to Host 2008 First Quarter Conference Call 3
... Pick one of our pipettors up and ... and ejector positionsright where they should beeven if ... designed to help avoid repetitive stress injuries caused ... The Palm Of Your Hand Start dispensing ...
... for Unparalleled Comfort Pick one of our ... Notice the trigger and ejector positionsright where they ... pipettors are ergonomically designed to help avoid repetitive ... Productivity In The Palm Of Your Hand ...
... ergonomic solution and best value in high ... action and ultra lightweight design reduce hand ... with long, lever tip ejector , Color ... universal tips or for greater performance use ...
... BioControl multichannel has the same ... channel model. The same universal ... and five single channel tip ... a recharge and storage stand ...
Medicine Products: